iBio, Inc. (IBIO)
1.90
-0.03
(-1.55%)
USD |
NASDAQ |
May 29, 16:00
1.91
+0.01
(+0.53%)
After-Hours: 20:00
iBio EPS Diluted (Quarterly) : -0.0646 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -0.591 |
| Ocugen, Inc. | -0.0586 |
| CytomX Therapeutics, Inc. | -0.1029 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.73M |
| Total Expenses (Quarterly) | 7.73M |
| Enterprise Value | 21.92M |
| Earnings Yield | -30.41% |
| Normalized Earnings Yield | -28.71 |